AzTrials
AzTrials

Hip FracturesNCT02699619

Undisplaced Femoral Neck Fractures 2 Hansson Pins or 3 Pins Interlocked in Plate (Pinloc) Using RSA

A study testing Pinloc and 2 Hansson pins in people with Hip Fractures and Femoral Neck Fractures, run by Oslo University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Femoral neck fractures represent about half of the hip fractures and are further divided into displaced and undisplaced fractures. Displaced femoral neck fractures are almost always treated surgically with arthroplasty. However there is an ongoing debate on which implant is superior for undisplaced fractures. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Hip Fractures, Femoral Neck Fractures
What is being tested?
Pinloc and 2 Hansson pins
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteNorway
Study dates
Mar 2016to May 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • undisplaced femoral neck fractures
  • able to walk independently, aids such as crutches or walker allowed
  • able to consent
  • fit for surgery with pins with or without plate

Who cannot join

  • not willing or able to attain follow up
  • previous fracture or surgery with retained metal work in the same hip
  • concomitant disease that will shorten life expectancy (i.e. cancer, COPD)

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Orthopedic Center, Ulleval University Hospital

    Oslo, 0408

Other trials in Norway

About this study

Official title: Undisplaced Femoral Neck Fractures Treated With 2 Hansson Pins Without Plate or 3 Hansson Pins Interlocked in a Plate (Pinloc) - A Randomized Controlled Trial Using Radiostereometry

Femoral neck fractures represent about half of the hip fractures and are further divided into displaced and undisplaced fractures. Displaced femoral neck fractures are almost always treated surgically with arthroplasty. However there is an ongoing debate on which implant is superior for undisplaced fractures.

A novel implant design (Pinloc) has been developed by Swemac Innovation AB. While the original implant consisted of 2 isolated hook pins, the modified design consists of 3 titanium hook pins interlocked in an aluminum plate. Interlocking is a new principle of implant design and improves fixation and load transfer amongst the pins. The superiority of the modified design is so far only proven preclinically.

The role of the Pinloc in clinical use remains unclear. Investigators are planning a randomized controlled trial on undisplaced femoral neck fractures to establish a method for implanting the tantalum markers, to observe the fracture healing process and to further investigate the role of the Pinloc.

Read the detailed description

Femoral neck fractures represent about half of the hip fractures and are further divided into displaced and undisplaced fractures. Displaced femoral neck fractures are almost always treated surgically with arthroplasty. However there is an ongoing debate on which implant is superior for undisplaced fractures.

A novel implant design (Pinloc) has been developed by Swemac Innovation AB. While the original implant consisted of 2 isolated hook pins, the modified design consists of 3 titanium hook pins interlocked in an aluminum plate. Interlocking is a new principle of implant design and improves fixation and load transfer amongst the pins. The superiority of the modified design is so far only proven preclinically. The role of the Pinloc in clinical use remains unclear.

A series of studies is now planned at Oslo University Hospital in collaboration with Diakonhjemmet Hospital in hope to further clarify this debate. The use of the Pinloc has been introduced in some regions (e.g. Norway, Sweden and Japan). The role of the Pinloc remains unclear and very little has been published on it's use, even though it is believed to be an important contributor of stability to the fixation.

Femoral neck fractures are mainly caused by a fall from own height in the elderly. The fractures are most often classified as displaced or not, using the simplified Garden classification. Several other classification systems also exist, but these have not been shown to be of reliable clinical usefulness. The ideal classification system should be easily applicable, reliable, and aid in treatment decision making and prognosis.

The treatment of femoral neck fractures comprise perioperative and operative modalities. The perioperative modalities consist among others of medical optimalization preoperatively, early rehabilitation and prevention of new fractures by treating osteoporosis and preventing new falls. The main scope of the current study will, however, be the operative modalities.

Surgery for undsiplaced femoral neck fractures is performed mainly with internal fixation on a traction table, using either screws, pins or a sliding hip screw (SHS), available in various designs from different manufacturers. The latest Cochrane review did not conclude on which implant is the superior.

Radiostereometry (RSA) is the most precise and accurate method to measure motion in vivo between different segments in orthopaedic research. To do so, radioopaque tantalum markers are implanted into the bone defining different segments. Stereoradiographs are performed over time to detect movement and monitor the healing (or non healing) process. This movement can be calculated both as translations and rotations. They are ideal to describe and compare the stability of fracture systems. RSA has been used successfully in earlier studies on fracture healing. Due to the high accuracy and precision, RSA yield reliable results with relatively small study-groups. Investigators plan to use RSA to measure fracture dislocation and time to healing in our studies. The study will be on the function of the Pinloc and it´s ability to prevent secondary dislocation in undisplaced femoral neck fractures. Investigators will utilize RSA for measurements during follow-up.

Being tested
Pinloc, 2 Hansson pins
Keywords
Undisplaced
Medical subject headings
Hip Fractures, Femoral Neck Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PinlocDevice

    Also called 3 hook pins interlocked in plate.

    3 hook pins interlocked in plate.

  • 2 Hansson pinsDevice

    Also called 2 isolated hook pins.

    2 isolated hook pins.(Without plate)

Study groups in NCT02699619
Study groupRoleWhat they receive
2 Hansson pins without plateActive comparatorPatients with undisplaced femoral neck fractures operated with 2 isolated Hansson pins.
Receives: Device: 2 Hansson pins
3 Hansson pins interlocked in a plateActive comparatorPatients with undisplaced femoral neck fractures operated with 3 Hansson pins interlocked in plate (Pinloc).
Receives: Device: Pinloc

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in fracture displacement during healing measured with radiostereometry

    Will be measured by RSA postoperatively, before discharge and after 4, 8, 12, 24 and 52 weeks. Total displacement from first reading to the reading showing maximum displacement is the main outcome.

    Measured: Up to 52 weeks

Secondary outcomes (26)
  1. Perioperative blood loss

    Measured: 1 week

  2. Time of surgery

    Measured: 1 week

  3. Eq5d

    Health Related Quality of Life (Hrqol).

    Measured: 52 weeks

  4. Eq5d

    Hrqol.

    Measured: 26 weeks

  5. Eq5d

    Hrqol.

    Measured: 12 weeks

  6. Eq5d

    Hrqol.

    Measured: 4 weeks

  7. Change in time to union as measured by RSA (cessation of motion) and radiographs

    When RSA shows that no motion has happened between two time points the fracture will be regarded as healed at the former time point.

    Measured: Will be examined at 4, 12, 26 and 52 weeks

  8. Change in time to union as measured by plain radiographs and clinical findings

    Composite endpoint: Healing defined by obliteration of fracture line radiographically and pain free weight bearing (except lateral pain from hardware), when this occurs the fracture will be considered healed.

    Measured: Will be examined at 4,12, 26 and 52 weeks

  9. Harris Hip Score

    Will be examined at 4,12, 26 and 52 weeks

    Measured: Up to 52 weeks

  10. Postoperative pain (NRS) while in hospital

    Pain at mobilization (NRS) at discharge

    Measured: 1 week

  11. Timed Up and Go test

    Tug

    Measured: 4 weeks

  12. Timed Up and Go test

    Tug

    Measured: 12 weeks

  13. Timed Up and Go test

    Tug

    Measured: 26 weeks

  14. Timed Up and Go test

    Tug

    Measured: 52 weeks

  15. Pain (NRS)

    Maximum hip pain during the last week

    Measured: 4 weeks

  16. Pain (NRS)

    Maximum hip pain during the last week

    Measured: 12 weeks

  17. Pain (NRS)

    Maximum hip pain during the last week

    Measured: 26 weeks

  18. Pain (NRS)

    Maximum hip pain during the last week

    Measured: 52 weeks

  19. Satisfaction with operated hip (NRS)

    NRS

    Measured: 4 weeks

  20. Satisfaction with operated hip (NRS)

    NRS

    Measured: 12 weeks

  21. Satisfaction with operated hip (NRS)

    NRS

    Measured: 26 weeks

  22. Satisfaction with operated hip (NRS)

    NRS

    Measured: 52 weeks

  23. Motion during healing as measured by radiostereometry.

    Will be measured by RSA postoperatively, before discharge and after 4, 12, 24 and 52 weeks.

    Measured: Up to 52 weeks

  24. Motion during healing as measured by plain radiographs.

    Will be measured by RSA postoperatively, before discharge and after 4,12, 24 and 52 weeks.

    Measured: Up to 52 weeks

  25. Reoperation for healing problems

    Any additional surgery addressing healing problems or hardware failure

    Measured: 52 weeks

  26. Mortality

    Any reason

    Measured: 52 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2016 (estimated)
  2. Study startMar 2016
  3. Primary completionApr 2021
  4. Study completionMay 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02699619
Sponsor's protocol ID
2015/191/REK SO B
Status last verified
May 2021
First submitted
20 Jan 2016
Last updated
11 May 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: International peer review journal

Questions about this trial

What is this clinical trial studying?

A study testing Pinloc and 2 Hansson pins in people with Hip Fractures and Femoral Neck Fractures, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in fracture displacement during healing measured with radiostereometry (time frame: Up to 52 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in